Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Comcast
CMCSA
|
+$1.97B |
| 2 |
Burlington
BURL
|
+$1.07B |
| 3 |
Philip Morris
PM
|
+$759M |
| 4 |
General Motors
GM
|
+$673M |
| 5 |
JPMorgan Chase
JPM
|
+$666M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$2.75B |
| 2 |
Netflix
NFLX
|
+$1.61B |
| 3 |
Mercado Libre
MELI
|
+$1.12B |
| 4 |
Illumina
ILMN
|
+$1.05B |
| 5 |
Amazon
AMZN
|
+$974M |
Sector Composition
| 1 | Technology | 19.95% |
| 2 | Healthcare | 19.04% |
| 3 | Communication Services | 14.79% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Purple Innovation
PRPL
$114M
| $69.4M | 0.02% |
+2,793,000
| New | +$69.4M |
|
302
Bentley Systems
BSY
$16.1B
| $67.5M | 0.02% |
+2,150,000
| New | +$67.5M |
|
|
COUP
303
DELISTED
Coupa Software Incorporated
COUP
| $66.8M | 0.02% |
243,524
-778,877
| -76% | -$214M |
|
304
Trupanion
TRUP
$1.87B
| $64.9M | 0.02% |
822,200
-151,600
| -16% | -$12M |
|
305
Wynn Resorts
WYNN
$12.6B
| $64.8M | 0.02% |
902,868
-2,430
| -0.3% | -$174K |
|
306
SouthState Bank Corporation
SSB
$10.2B
| $64.2M | 0.02% |
1,333,300
+596,300
| +81% | +$28.7M |
|
307
LivaNova
LIVN
$3.07B
| $63.5M | 0.02% |
1,404,015
+152
| +0% | +$6.87K |
|
308
East-West Bancorp
EWBC
$15.1B
| $63.4M | 0.02% |
1,937,900
-191,507
| -9% | -$6.27M |
|
309
PAR Technology
PAR
$1.79B
| $62.6M | 0.02% |
1,545,543
+446,583
| +41% | +$18.1M |
|
310
Wells Fargo
WFC
$261B
| $61.1M | 0.02% |
2,598,259
| – | – |
|
311
Vroom, Inc. Common Stock
VRM
$137M
| $60.8M | 0.02% |
14,688
| – | – |
|
312
MACOM Technology Solutions
MTSI
$9.82B
| $60.1M | 0.02% |
1,767,000
-1,614,000
| -48% | -$54.9M |
|
313
Globus Medical
GMED
$7.93B
| $60.1M | 0.02% |
1,213,200
-229,300
| -16% | -$11.4M |
|
|
CMRC
314
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $58.3M | 0.02% |
+700,000
| New | +$58.3M |
|
315
Boston Scientific
BSX
$152B
| $57.8M | 0.02% |
1,511,525
-1,155,238
| -43% | -$44.1M |
|
|
RDS.A
316
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $57.7M | 0.02% |
2,293,670
-31,765
| -1% | -$800K |
|
317
Skechers
SKX
| $57.4M | 0.02% |
1,900,000
+400,000
| +27% | +$12.1M |
|
318
Fiserv
FI
$73B
| $55.3M | 0.02% |
536,703
+3
| +0% | +$309 |
|
319
Pfizer
PFE
$136B
| $55.2M | 0.02% |
1,584,023
-3,763,008
| -70% | -$131M |
|
320
CONMED
CNMD
$1.64B
| $54.6M | 0.02% |
694,500
+110,000
| +19% | +$8.65M |
|
321
PNC Financial Services
PNC
$79.5B
| $51.6M | 0.02% |
469,126
+55
| +0% | +$6.05K |
|
322
Rapid7
RPD
$1.27B
| $51M | 0.02% |
833,000
| – | – |
|
323
BP
BP
$87.3B
| $50.4M | 0.02% |
2,884,071
-5,394
| -0.2% | -$94.2K |
|
|
EVRI
324
DELISTED
Everi Holdings
EVRI
| $49.3M | 0.01% |
5,974,959
+300,000
| +5% | +$2.47M |
|
325
Robert Half
RHI
$3.61B
| $48.6M | 0.01% |
917,800
-523,000
| -36% | -$27.7M |
|